These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 29879262)

  • 1. Topical Vehicle Formulations in the Treatment of Acne.
    Hoffman LK; Bhatia N; Zeichner J; Kircik LH
    J Drugs Dermatol; 2018 Jun; 17(6):s6-s10. PubMed ID: 29879262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized tolerability analysis of clindamycin phosphate 1.2%-tretinoin 0.025% gel used with benzoyl peroxide wash 4% for acne vulgaris.
    Draelos ZD; Potts A; Alió Saenz AB;
    Cutis; 2010 Dec; 86(6):310-8. PubMed ID: 21284283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clindamycin phosphate 1.2%- tretinoin 0.025% gel: vehicle characteristics, stability, and tolerability.
    Del Rosso JQ; Jitpraphai W; Bhambri S; Momin S
    Cutis; 2008 May; 81(5):405-8. PubMed ID: 18543590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical Retinoids in Acne Vulgaris: A Systematic Review.
    Kolli SS; Pecone D; Pona A; Cline A; Feldman SR
    Am J Clin Dermatol; 2019 Jun; 20(3):345-365. PubMed ID: 30674002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving treatment outcomes: tolerability of a fixed-combination clindamycin 1%-benzoyl peroxide 5% hydrating gel as monotherapy or in combination with a retinoid.
    Eichenfield L
    Cutis; 2009 Nov; 84(5 Suppl):12-7. PubMed ID: 19999188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris.
    Zaenglein AL; Shamban A; Webster G; Del Rosso J; Dover JS; Swinyer L; Stein L; Lin X; Draelos Z; Gold M; Thiboutot D
    J Drugs Dermatol; 2013 Jun; 12(6):619-25. PubMed ID: 23839176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerability and Efficacy of Clindamycin/Tretinoin versus Adapalene/Benzoyl Peroxide in the Treatment of Acne Vulgaris.
    Aschoff R; Möller S; Haase R; Kuske M
    J Drugs Dermatol; 2021 Mar; 20(3):295-301. PubMed ID: 33683070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzoyl peroxide: enhancing antibiotic efficacy in acne management.
    Dutil M
    Skin Therapy Lett; 2010; 15(10):5-7. PubMed ID: 21076800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fixed-combination clindamycin 1%-benzoyl peroxide 5% hydrating gel: a flexible component of acne management.
    Tanghetti E
    Cutis; 2009 Nov; 84(5 Suppl):18-24. PubMed ID: 19999189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clindamycin phosphate-tretinoin combination gel revisited: status report on a specific formulation used for acne treatment.
    Del Rosso JQ
    Cutis; 2017 Mar; 99(3):179-183. PubMed ID: 28398420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of vehicle formulation on acne medication tolerability.
    Draelos ZD; Callender V; Young C; Dhawan SS
    Cutis; 2008 Oct; 82(4):281-4. PubMed ID: 19055172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cumulative irritancy comparison of topical retinoid and antimicrobial combination therapies.
    Dosik JS; Gilbert RD; Arsonnaud S
    Skinmed; 2006; 5(5):219-23. PubMed ID: 16957432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination topical therapy in the treatment of acne.
    Del Rosso JQ
    Cutis; 2006 Aug; 78(2 Suppl 1):5-12. PubMed ID: 17966494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging topical antimicrobial options for mild-to-moderate acne: a review of the clinical evidence.
    Del Rosso J
    J Drugs Dermatol; 2008 Feb; 7(2 Suppl):s2-7. PubMed ID: 18404864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter, double-blind study to evaluate the efficacy and safety of 2 treatments in participants with mild to moderate acne vulgaris.
    Draelos ZD; Shalita AR; Thiboutot D; Oresajo C; Yatskayer M; Raab S
    Cutis; 2012 Jun; 89(6):287-93. PubMed ID: 22838094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining clindamycin 1%-benzoyl peroxide 5% gel with multiple therapeutic options.
    Bikowski J; Callender VD; Del Rosso JQ; Draelos ZD; Tanghetti E
    Cutis; 2006 Aug; 78(2 Suppl 1):13-20. PubMed ID: 17966495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing topical combination therapy for the treatment of acne vulgaris.
    Zeichner JA
    J Drugs Dermatol; 2012 Mar; 11(3):313-7. PubMed ID: 22395581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in topical delivery systems in acne: new solutions to address concentration dependent irritation and dryness.
    Ceilley RI
    Skinmed; 2011; 9(1):15-21. PubMed ID: 21409958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibiotics, azelaic acid and benzoyl peroxide in topical acne therapy].
    Fluhr JW; Degitz K
    J Dtsch Dermatol Ges; 2010 Mar; 8 Suppl 1():S24-30. PubMed ID: 20482689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of clindamycin/benzoyl peroxide, tretinoin plus clindamycin, and the combination of clindamycin/benzoyl peroxide and tretinoin plus clindamycin in the treatment of acne vulgaris: a randomized, blinded study.
    Bowman S; Gold M; Nasir A; Vamvakias G
    J Drugs Dermatol; 2005; 4(5):611-8. PubMed ID: 16167420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.